Cargando…

A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India

OBJECTIVE: This prospective observational study was carried out to identify the prevalence and Severity of ADRs of antidepressant in a tertiary care teaching hospital. MATERIALS AND METHODS: Patients prescribed with at least one antidepressant were randomly selected and monitored for adverse drug re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucca, Jisha M., Madhan, Ramesh, Gurumurthy, Parthasarathi, Dushad, Ram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175893/
https://www.ncbi.nlm.nih.gov/pubmed/25298586
http://dx.doi.org/10.4103/0253-7613.140591
_version_ 1782336551900938240
author Lucca, Jisha M.
Madhan, Ramesh
Gurumurthy, Parthasarathi
Dushad, Ram
author_facet Lucca, Jisha M.
Madhan, Ramesh
Gurumurthy, Parthasarathi
Dushad, Ram
author_sort Lucca, Jisha M.
collection PubMed
description OBJECTIVE: This prospective observational study was carried out to identify the prevalence and Severity of ADRs of antidepressant in a tertiary care teaching hospital. MATERIALS AND METHODS: Patients prescribed with at least one antidepressant were randomly selected and monitored for adverse drug reactions (ADRs), irrespective of their age and gender. RESULTS: Of the 401 patients who received antidepressants, 170 patients (42.39%) experienced 204 ADRs. Selective serotonin receptor inhibitors (SSRIs) [110 (53.92)] was the most common therapeutic class of drugs associated with ADRs. Gastrointestinal system [54 (26.47)] was most commonly affected system organ class. Dry mouth (n = 30) and diaphoresis (n = 21) were the most frequently reported ADRs. As assessed by the World Health organization (WHO) probability scale, 61% of the ADRs were ‘probable’ causality. Among all the ADRs, 22.54% (46) were preventable. Majority of the ADRs [(n = 184) 90.17%] were ‘mild’ in their severity. CONCLUSION: In this study, incidence of adverse reaction to antidepressants was 42.3% were the most comman SSRI inplicated drug group for the ADRs.
format Online
Article
Text
id pubmed-4175893
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-41758932014-10-08 A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India Lucca, Jisha M. Madhan, Ramesh Gurumurthy, Parthasarathi Dushad, Ram Indian J Pharmacol Short Communication OBJECTIVE: This prospective observational study was carried out to identify the prevalence and Severity of ADRs of antidepressant in a tertiary care teaching hospital. MATERIALS AND METHODS: Patients prescribed with at least one antidepressant were randomly selected and monitored for adverse drug reactions (ADRs), irrespective of their age and gender. RESULTS: Of the 401 patients who received antidepressants, 170 patients (42.39%) experienced 204 ADRs. Selective serotonin receptor inhibitors (SSRIs) [110 (53.92)] was the most common therapeutic class of drugs associated with ADRs. Gastrointestinal system [54 (26.47)] was most commonly affected system organ class. Dry mouth (n = 30) and diaphoresis (n = 21) were the most frequently reported ADRs. As assessed by the World Health organization (WHO) probability scale, 61% of the ADRs were ‘probable’ causality. Among all the ADRs, 22.54% (46) were preventable. Majority of the ADRs [(n = 184) 90.17%] were ‘mild’ in their severity. CONCLUSION: In this study, incidence of adverse reaction to antidepressants was 42.3% were the most comman SSRI inplicated drug group for the ADRs. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4175893/ /pubmed/25298586 http://dx.doi.org/10.4103/0253-7613.140591 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Lucca, Jisha M.
Madhan, Ramesh
Gurumurthy, Parthasarathi
Dushad, Ram
A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India
title A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India
title_full A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India
title_fullStr A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India
title_full_unstemmed A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India
title_short A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India
title_sort prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in india
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175893/
https://www.ncbi.nlm.nih.gov/pubmed/25298586
http://dx.doi.org/10.4103/0253-7613.140591
work_keys_str_mv AT luccajisham aprospectiveobservationalstudytoevaluatesafetyreportingofantidepressantsatatertiarycarehospitalinindia
AT madhanramesh aprospectiveobservationalstudytoevaluatesafetyreportingofantidepressantsatatertiarycarehospitalinindia
AT gurumurthyparthasarathi aprospectiveobservationalstudytoevaluatesafetyreportingofantidepressantsatatertiarycarehospitalinindia
AT dushadram aprospectiveobservationalstudytoevaluatesafetyreportingofantidepressantsatatertiarycarehospitalinindia
AT luccajisham prospectiveobservationalstudytoevaluatesafetyreportingofantidepressantsatatertiarycarehospitalinindia
AT madhanramesh prospectiveobservationalstudytoevaluatesafetyreportingofantidepressantsatatertiarycarehospitalinindia
AT gurumurthyparthasarathi prospectiveobservationalstudytoevaluatesafetyreportingofantidepressantsatatertiarycarehospitalinindia
AT dushadram prospectiveobservationalstudytoevaluatesafetyreportingofantidepressantsatatertiarycarehospitalinindia